LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,928 | -26.3% | 3,904 | -11.4% | 0.14% | -24.5% |
| Q2 2023 | $317,601 | -10.1% | 4,405 | -8.3% | 0.19% | -3.1% |
| Q1 2023 | $353,382 | +12.1% | 4,804 | +1.8% | 0.19% | +17.6% |
| Q4 2022 | $315,363 | +16.4% | 4,721 | +49.9% | 0.16% | +52.8% |
| Q3 2022 | $271,000 | -2.2% | 3,149 | +1.5% | 0.11% | +4.9% |
| Q2 2022 | $277,000 | -5.1% | 3,103 | +19.4% | 0.10% | -21.4% |
| Q1 2022 | $292,000 | -27.2% | 2,598 | 0.0% | 0.13% | -13.2% |
| Q4 2021 | $401,000 | -22.4% | 2,598 | -30.0% | 0.15% | -33.5% |
| Q3 2021 | $517,000 | -2.8% | 3,714 | -8.5% | 0.23% | +3.7% |
| Q2 2021 | $532,000 | -43.2% | 4,057 | -34.0% | 0.22% | -44.7% |
| Q1 2021 | $937,000 | +57.5% | 6,147 | +2.8% | 0.40% | +60.3% |
| Q4 2020 | $595,000 | +16.7% | 5,979 | +11.7% | 0.25% | -7.5% |
| Q3 2020 | $510,000 | -6.9% | 5,354 | +9.2% | 0.27% | +2.7% |
| Q2 2020 | $548,000 | +36.0% | 4,903 | -11.6% | 0.26% | +56.6% |
| Q1 2020 | $403,000 | -35.7% | 5,547 | -7.8% | 0.17% | +61.2% |
| Q4 2019 | $627,000 | -2.5% | 6,015 | -6.8% | 0.10% | -20.8% |
| Q3 2019 | $643,000 | -25.2% | 6,455 | -14.3% | 0.13% | -28.2% |
| Q2 2019 | $860,000 | +24.3% | 7,536 | +36.9% | 0.18% | -87.7% |
| Q1 2019 | $692,000 | +18.1% | 5,503 | +27.3% | 1.47% | +1372.0% |
| Q4 2018 | $586,000 | -47.6% | 4,322 | +6.1% | 0.10% | -13.8% |
| Q3 2018 | $1,119,000 | +42.2% | 4,075 | +7.2% | 0.12% | -83.3% |
| Q2 2018 | $787,000 | -29.6% | 3,800 | -43.9% | 0.70% | -28.2% |
| Q1 2018 | $1,118,000 | +14.0% | 6,771 | -5.4% | 0.97% | -21.2% |
| Q4 2017 | $981,000 | -19.5% | 7,161 | -20.0% | 1.23% | +650.6% |
| Q3 2017 | $1,218,000 | +12.2% | 8,947 | 0.0% | 0.16% | +1.2% |
| Q2 2017 | $1,086,000 | +6.4% | 8,947 | -7.2% | 0.16% | -11.0% |
| Q1 2017 | $1,021,000 | +15.4% | 9,642 | +10.6% | 0.18% | -31.1% |
| Q4 2016 | $885,000 | +61.2% | 8,714 | +61.9% | 0.26% | -0.4% |
| Q3 2016 | $549,000 | -2.1% | 5,382 | +14.4% | 0.26% | -36.3% |
| Q2 2016 | $561,000 | -5.6% | 4,705 | -15.1% | 0.42% | -49.1% |
| Q1 2016 | $594,000 | – | 5,543 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |